193 related articles for article (PubMed ID: 9457821)
1. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy.
Moran M; Haffty BG
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):353-8. PubMed ID: 9457821
[TBL] [Abstract][Full Text] [Related]
2. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
[TBL] [Abstract][Full Text] [Related]
3. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy.
Abner AL; Connolly JL; Recht A; Bornstein B; Nixon A; Hetelekidis S; Silver B; Harris JR; Schnitt SJ
Cancer; 2000 Mar; 88(5):1072-7. PubMed ID: 10699897
[TBL] [Abstract][Full Text] [Related]
4. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
Ben-David MA; Kleer CG; Paramagul C; Griffith KA; Pierce LJ
Cancer; 2006 Jan; 106(1):28-34. PubMed ID: 16329136
[TBL] [Abstract][Full Text] [Related]
5. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
[TBL] [Abstract][Full Text] [Related]
6. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
7. Lobular carcinoma in situ: observation without surgery as an appropriate therapy.
Carson W; Sanchez-Forgach E; Stomper P; Penetrante R; Tsangaris TN; Edge SB
Ann Surg Oncol; 1994 Mar; 1(2):141-6. PubMed ID: 7834439
[TBL] [Abstract][Full Text] [Related]
8. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
[TBL] [Abstract][Full Text] [Related]
9. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
[TBL] [Abstract][Full Text] [Related]
10. Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary?
Sadek BT; Shenouda MN; Abi Raad RF; Niemierko A; Keruakous AR; Goldberg SI; Taghian AG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):726-30. PubMed ID: 24064317
[TBL] [Abstract][Full Text] [Related]
11. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?
Cutuli B; de Lafontan B; Quetin P; Mery E
Eur J Cancer; 2005 Feb; 41(3):380-5. PubMed ID: 15691636
[TBL] [Abstract][Full Text] [Related]
12. Lobular carcinoma in situ and invasive cancer: the contralateral breast controversy.
Carolin KA; Tekyi-Mensah S; Pass HA
Breast J; 2002; 8(5):263-8. PubMed ID: 12199752
[TBL] [Abstract][Full Text] [Related]
13. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.
Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS
Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380
[TBL] [Abstract][Full Text] [Related]
14. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N
Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756
[TBL] [Abstract][Full Text] [Related]
15. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
[TBL] [Abstract][Full Text] [Related]
16. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
17. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.
Miller ME; Muhsen S; Zabor EC; Flynn J; Olcese C; Giri D; Van Zee KJ; Pilewskie M
Ann Surg Oncol; 2019 Dec; 26(13):4317-4325. PubMed ID: 31552614
[TBL] [Abstract][Full Text] [Related]
18. Current management of noninvasive (in situ) breast cancer.
Silverstein MJ
Adv Surg; 2000; 34():17-41. PubMed ID: 10997214
[No Abstract] [Full Text] [Related]
19. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status.
Stolier AJ; Barre G; Bolton JS; Fuhrman GM; Looney S
Am Surg; 2004 Sep; 70(9):818-21. PubMed ID: 15481302
[TBL] [Abstract][Full Text] [Related]
20. Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?
Beck AC; Bayard S; Plitas G; Sevilimedu V; Kuba MG; Garcia P; Morrow M; Tadros AB
Ann Surg Oncol; 2023 Oct; 30(10):6061-6069. PubMed ID: 37493892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
